Acta Scientific Neurology (ASNE) (ISSN: 2582-1121)

Mini Review Volume 5 Issue 4

A Novel Corona Virus: Impact on Cognitive Disorder

Ranjitha M1* and Hanumanthachar Joshi2

1Department of Pharmacology, Sarada Vilas College of Pharmacy, Mysore, India
2Principal, Department of Pharmacognosy, Sarada Vilas College of Pharmacy, Mysore, India

*Corresponding Author:Ranjitha M, Department of Pharmacology, Sarada Vilas College of Pharmacy, Mysore, India.

Received: March 11, 2022; Published: March 25, 2022

Abstract

A wide range of viruses are a raising in different geographical areas with different virus families because of their neurotropic characters. Infection by these neurotropic viruses can directly interrupt the structural and functional complexity of the central nervous system leads impairment in cognitive disorder. Keeping in this aspect, some of the research established that the Corona virus also belongs to a neurotropic virus which was first isolated as a pathogen from the respiratory tract. SARS-COV-2 was jumped to a human at one of the wet markets present in Wuhan through open air. This was first identified in 1965 with a crown-like appearance. Seven types of Coronavirus can affect humans, but out of seven SARS emerged in southern China in 2002. In 2003, 8,000 people were affected with SARS and the small outbreak was made in 2004 with four cases but suddenly 54 cases were reported viral pneumonia which was first emerged in Wuhan, China. Noticed that SARS-affected patients experienced CNS defects during their course of quarantine illness. At present COVID-19 pandemic rocketed around the globe in 2019 by disrupting functions of another system of the body like the CV system and CNS. A better understanding of molecular, epidemiological, and pathological characteristics of this infection with a CNS system with a particular mechanism may be expected to provide tools for the development of more effective intervention strategies by reducing the release of chemomediators in the brain from the inflammatory process which would prevent the structural complex of BBB of the CNS.

Keywords: COVID- 19; SARS Virus; Inflammatory Mediators; Central Nervous System

References

  1. Kahn JS and McIntosh K. “History and recent advances in coronavirus discovery”. The Pediatric Infectious Disease Journal 24 (2005): S223-S227.
  2. Who. “COVID- 19 Mythbusters - World Health Organization” (2021).
  3. Centers for Disease Control and Prevention. Coronavirus Disease  (COVID- 19) - Symptoms (2021).
  4. Mental help. Introduction to Cognitive Disorders (2021).
  5. Heneka MT., et al. “Immediate and long-term consequences of COVID- 19 infections for the development of neurological disease”. Alzheimer's Research and Therapy 2.1 (2020): 3.
  6. Carda S., et al. “COVID- 19 pandemic. What should Physical and Rehabilitation Medicine specialists do? A clinician’s perspective”. European Journal of Physical and Rehabilitation Medicine 56.4 (2020).
  7. <https://www.longdom.org/scholarly/cognitive-disorders-journals-articles-ppts-list2527.html.
  8. PsychGuides. “Cognitive Problem Symptoms, Causes and Effects – PsychGuides” (2021).
  9. Tronson N. “How COVID- 19 Might Increase the Risk of Memory Loss and Cognitive Decline - The Wire Science” (2021).
  10. Ludlow M., et al. “Neurotropic virus infections as the cause of immediate and delayed neuropathology”. Acta Neuropathologica 3.2 (2016): 59-84.
  11. Xu J., et al. “Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine mig in pathogenesis”. Clinical Infectious Diseases 4.8 (2005): 089-096.
  12. Adams JL., et al. “Telemedicine: a valuable tool in neurodegenerative diseases”. Current Geriatrics Reports 9.2 (2020): 72-81.
  13. Guessoum SB., et al. “Adolescent psychiatric disorders during the COVID- 19 pandemic and lockdown”. Psychiatry Research (2020): 3264.
  14. Bianchetti A., et al. “Clinical presentation of COVID 19 in dementia patients”. The Journal of Nutrition, Health and Aging 24 (20202): 560-562.
  15. Zhou H., et al. “The landscape of cognitive function in recovered COVID- 9 patients”. Journal of Psychiatric Research 29 (2020): 98-102.
  16. Andrew E and Budson M. “The hidden long-term cognitive effects of COVID- 19 - Harvard Health Blog” (2021).
  17. How COVID- 19 attacks the brain (2021).
  18. Villani ER., et al. “Impact of COVID- 19Related Lockdown on Psychosocial, Cognitive, and Functional Well-Being in Adults with Down Syndrome”. Frontiers in Psychiatry (2020): 150.
  19.  

Citation

Citation: Ranjitha M and Hanumanthachar Joshi. “A Novel Corona Virus: Impact on Cognitive Disorder". Acta Scientific Neurology 5.4 (2022): 15-18.

Copyright

Copyright: © 2022 Ranjitha M and Hanumanthachar Joshi. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate32%
Acceptance to publication20-30 days

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is May 25, 2022.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US